Cover Image
市場調查報告書

植入式心臟整流去顫器 (ICD) :醫療設備的開發平台評估

Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 357838
出版日期 內容資訊 英文 98 Pages
訂單完成後即時交付
價格
Back to Top
植入式心臟整流去顫器 (ICD) :醫療設備的開發平台評估 Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年08月04日 內容資訊: 英文 98 Pages
簡介

本報告提供植入式心臟整流去顫器 (ICD) 相關之開發中產品調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的近幾年趨勢等資訊。

第1章 目錄

第2章 簡介

  • 植入式心臟整流去顫器 (ICD)概要

第3章 開發中的產品

  • 植入式心臟整流去顫器 (ICD) - 開發中產品:各開發階段
  • 植入式心臟整流去顫器 (ICD) - 開發中產品:各市場區隔
  • 植入式心臟整流去顫器 (ICD) - 開發中產品:各地區 (國家)
  • 植入式心臟整流去顫器 (ICD) - 開發中產品:各法規途徑
  • 植入式心臟整流去顫器 (ICD) - 開發中產品:各核准時期 (估計)
  • 植入式心臟整流去顫器 (ICD) - 持續中臨床實驗

第4章 植入式心臟整流去顫器 (ICD) - 正在開發的開發中產品:各企業

  • 植入式心臟整流去顫器 (ICD)企業 - 開發中產品:各開發階段
  • 植入式心臟整流去顫器 (ICD) - 開發中產品:各開發階段

第5章 植入式心臟整流去顫器 (ICD) 開發企業與產品概要

  • AIS Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardiaLen, Inc.
  • InnerPulse, Inc.
  • Kenergy Inc.
  • Max Planck Institute for Dynamics and Self-Organization
  • Medtronic plc
  • Smartwave Medical Ltd
  • The Johns Hopkins University
  • University of Leicester

第6章 植入式心臟整流去顫器 (ICD) - 近幾年趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0409EPD

GlobalData's Medical Devices sector report, "Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2017" provides an overview of Implantable Cardioverter Defibrillators (ICD) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Cardioverter Defibrillators (ICD) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Implantable Cardioverter Defibrillators (ICD) Overview 6

3 Products under Development 7

  • 3.1 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 7
  • 3.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment 8
  • 3.3 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory 9
  • 3.4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path 10
  • 3.5 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date 11
  • 3.6 Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials 12

4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products under Development by Companies 13

  • 4.1 Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development 13
  • 4.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 14

5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview 15

  • 5.1 AIS Inc. Company Overview 15
    • 5.1.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.2 Boston Scientific Corp Company Overview 16
    • 5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 CardiaLen, Inc. Company Overview 24
    • 5.3.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.4 InnerPulse, Inc. Company Overview 26
    • 5.4.1 InnerPulse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.5 John Hopkins University Company Overview 27
    • 5.5.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.6 Kenergy Inc. Company Overview 29
    • 5.6.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.7 Max Planck Institute for Dynamics and Self-Organization Company Overview 30
    • 5.7.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.8 Medtronic plc Company Overview 31
    • 5.8.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.9 Smartwave Medical Ltd Company Overview 37
    • 5.9.1 Smartwave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

6 Implantable Cardioverter Defibrillators (ICD)- Recent Developments 38

  • 6.1 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 38
  • 6.2 Jul 26, 2017: CONMED Announces Second Quarter 2017 Financial Results 39
  • 6.3 Jul 24, 2017: Philips' Second Quarter Results 2017 40
  • 6.4 Jul 20, 2017: Chief Business Leader of Philips' Personal Health businesses Pieter Nota to leave company 43
  • 6.5 Jul 19, 2017: Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology For Heart Failure Patients 43
  • 6.6 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 44
  • 6.7 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 46
  • 6.8 May 11, 2017: Boston Scientific S-ICD System Demonstrates Positive Clinical Outcomes in the Largest Prospective Study of 'Real-World' Patients 49
  • 6.9 May 11, 2017: BIOTRONIK Home Monitoring Reduces All-Cause Mortality in ICD Patients 50
  • 6.10 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 50
  • 6.11 Apr 26, 2017: CONMED Announces First Quarter 2017 Financial Results 51
  • 6.12 Apr 24, 2017: Philips' First Quarter Results 2017 52
  • 6.13 Apr 19, 2017: Rochester Researchers Lead First Worldwide Trial to Test Defibrillators in Diabetes Patients 54
  • 6.14 Apr 18, 2017: Boston Scientific Initiates Global Study To Assess Sudden Cardiac Arrest Prevention Therapy In Patients With Diabetes Who Have Previously Experienced A Heart Attack 56
  • 6.15 Mar 20, 2017: Philips reclassified to STOXX Europe 600 Health Care sector index 56
  • 6.16 Mar 17, 2017: Philips appoints Henk de Jong as Chief of International Markets 57
  • 6.17 Mar 07, 2017: Philips leads the world in filing patents at the European Patent Office for second consecutive year 57
  • 6.18 Feb 21, 2017: Philips increases Green Revenues to EUR 10.2 billion, 58% of HealthTech revenues in 2016 58
  • 6.19 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 59
  • 6.20 Feb 14, 2017: Philips announces changes to its Executive Committee 61
  • 6.21 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 62
  • 6.22 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 63
  • 6.23 Feb 01, 2017: CONMED Announces Fourth Quarter and Fiscal Year 2016 Financial Results 64
  • 6.24 Jan 24, 2017: Philips' Fourth Quarter and Annual Results 2016 66
  • 6.25 Jan 19, 2017: Philips appoints Roy Smythe as Chief Medical Officer for Health Informatics 68
  • 6.26 Dec 23, 2016: Philips and leading network of healthcare centers and clinics in Russia to modernize the country's regional healthcare infrastructures 69
  • 6.27 Dec 19, 2016: Opto Circuits and its subsidiaries receives orders worth Rs. 910 millions from Philips Health Care 70
  • 6.28 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 70
  • 6.29 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 73
  • 6.30 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 73
  • 6.31 Nov 09, 2016: ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference 74
  • 6.32 Nov 07, 2016: BIOTRONIK Launches First and Only 42 Joule Ultra-High Energy ICD for Heart Failure Patients 76
  • 6.33 Oct 27, 2016: CONMED Announces Third Quarter 2016 Financial Results 76
  • 6.34 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 77
  • 6.35 Oct 26, 2016: Nihon Kohden Announces Consolidation and Relocation of Offices 79
  • 6.36 Oct 24, 2016: Philips' Third Quarter Results 2016 79
  • 6.37 Oct 24, 2016: St. Jude Medical Recalls Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators Due to Premature Battery Depletion 81
  • 6.38 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 82
  • 6.39 Oct 11, 2016: St. Jude Medical - Important Medical Device Advisory 83
  • 6.40 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 84
  • 6.41 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 85
  • 6.42 Sep 07, 2016: St. Jude Medical Brings Legal Action Against Muddy Waters and MedSec 86
  • 6.43 Sep 05, 2016: BIOTRONIK First Launches ICDs with Exclusive MRI AutoDetect Feature in Japan 87
  • 6.44 Sep 01, 2016: Philips appoints Sophie Bechu as Chief of Operations 87
  • 6.45 Aug 31, 2016: New ICD trial involving patients with symptomatic systolic heart faliure 88
  • 6.46 Aug 30, 2016: St. Jude Medical Continues to Refute Allegations made by Muddy Waters Capital and MedSec 88
  • 6.47 Aug 26, 2016: St. Jude Medical Refutes Muddy Waters Device Security Allegations and Reinforces Security of Devices and Commitment to Patient Safety 89
  • 6.48 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 91
  • 6.49 Aug 09, 2016: Boston Scientific Announces U.S. FDA Approval Of EMBLEM MRI S-ICD System 94

7 Appendix 95

  • 7.1 Methodology 95
  • 7.2 About GlobalData 98
  • 7.3 Contact Us 98
  • 7.4 Disclaimer 98

List of Tables

1.1 List of Tables

  • Table 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 7
  • Table 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment 8
  • Table 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory 9
  • Table 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path 10
  • Table 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date 11
  • Table 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials 12
  • Table 7: Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development 13
  • Table 8: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 14
  • Table 9: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 10: Guardian - Product Status 15
  • Table 11: Guardian - Product Description 15
  • Table 12: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 13: EMBLEM MRI S-ICD System - Aged Patients - Product Status 16
  • Table 14: EMBLEM MRI S-ICD System - Aged Patients - Product Description 17
  • Table 15: EMBLEM S-ICD - Product Status 17
  • Table 16: EMBLEM S-ICD - Product Description 17
  • Table 17: MRI Compatible S-ICD - Product Status 18
  • Table 18: MRI Compatible S-ICD - Product Description 18
  • Table 19: S-ICD System 1.5 - Product Status 18
  • Table 20: S-ICD System 1.5 - Product Description 19
  • Table 21: S-ICD System 2.0 - Product Status 19
  • Table 22: S-ICD System 2.0 - Product Description 19
  • Table 23: VITALITY NXT Defibrillator - Product Status 20
  • Table 24: VITALITY NXT Defibrillator - Product Description 20
  • Table 25: Boston Scientific Corp - Ongoing Clinical Trials Overview 21
  • Table 26: EMBLEM S-ICD - Avoid Transvenous Leads in Appropriate Subjects 22
  • Table 27: EMBLEM S-ICD - Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low Ejection Fraction 22
  • Table 28: EMBLEM MRI S-ICD System - Aged Patients - Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator: MADIT S-ICD 23
  • Table 29: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 30: CardiaLen Device - Atrial Fibrillation - Product Status 24
  • Table 31: CardiaLen Device - Atrial Fibrillation - Product Description 24
  • Table 32: CardiaLen Device - Ventricular Arrhythmia - Product Status 25
  • Table 33: CardiaLen Device - Ventricular Arrhythmia - Product Description 25
  • Table 34: InnerPulse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 35: PICD - Product Status 26
  • Table 36: PICD - Product Description 26
  • Table 37: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 38: Cardiac Sock Electrode And Implantable Defibrillator System - Product Status 27
  • Table 39: Cardiac Sock Electrode And Implantable Defibrillator System - Product Description 27
  • Table 40: Implantable Cardioverter Defibrillator System - Product Status 28
  • Table 41: Implantable Cardioverter Defibrillator System - Product Description 28
  • Table 42: Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 43: Unconditional MRI Compatible Implantable Defibrillator - Product Status 29
  • Table 44: Unconditional MRI Compatible Implantable Defibrillator - Product Description 29
  • Table 45: Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 46: Implantable Defibrillator - Product Status 30
  • Table 47: Implantable Defibrillator - Product Description 30
  • Table 48: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 49: Chronicle ICD - Product Status 31
  • Table 50: Chronicle ICD - Product Description 31
  • Table 51: EV-ICD System - Product Status 32
  • Table 52: EV-ICD System - Product Description 32
  • Table 53: Visia AF MRI SureScan Single-chamber ICD - Product Status 32
  • Table 54: Visia AF MRI SureScan Single-chamber ICD - Product Description 33
  • Table 55: Medtronic plc - Ongoing Clinical Trials Overview 34
  • Table 56: Chronicle ICD - Incidence of Arrhythmias in Spanish Population with a Medtronic ICD Implant: UMBRELLA 35
  • Table 57: EV-ICD System - Incidence of Arrhythmias in Spanish Population with a Medtronic ICD Implant: UMBRELLA 36
  • Table 58: Smartwave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 59: Fully Automatic Implantable Atrial Defibrillator - Product Status 37
  • Table 60: Fully Automatic Implantable Atrial Defibrillator - Product Description 37
  • Table 61: Glossary 97

List of Figures

1.2 List of Figures

  • Figure 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 7
  • Figure 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment 8
  • Figure 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory 9
  • Figure 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path 10
  • Figure 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date 11
  • Figure 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials 12
Back to Top